BioNTech SE (BNTX) vs Centene Corporation (CNC)
CNC leads on 6 of 10 compared metrics.
A side-by-side comparison of BioNTech SE and Centene Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 18, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BNTX vs CNC
growth of $100 · last 7yBNTX +547.6%CNC +37.5%BNTX compounded faster
BNTX CNC
BNTX vs CNC: by the numbers
- •CNC is the larger company ($29.94B vs $23.32B market cap).
- •Both run net losses; CNC's is the smaller (-3.25% vs -44.73% net margin).
- •CNC grew revenue faster over the past five years (11.48% vs 2.16% CAGR).
Which is better, BNTX or CNC?
Metric tally: BNTX 4 · CNC 6It depends on what you're optimizing for:
GrowthCNC(faster 5Y revenue CAGR)
QualityBNTX(higher ROIC)
Metrics side by side
Valuation
| Metric | BNTX | CNC |
|---|---|---|
| Forward P/E | — | 13.48 |
| P/S ratio | 7.10 | 0.15● |
| P/B ratio | 1.08● | 1.40 |
| FCF yield | 6.41% | 21.10%● |
Profitability
| Metric | BNTX | CNC |
|---|---|---|
| Gross margin | 73.26%● | 14.93% |
| Operating margin | -51.55% | -3.68%● |
| Net margin | -44.73% | -3.25%● |
| ROE | -6.79%● | -30.07% |
| ROIC | -3.14%● | -13.41% |
Growth (annualized)
| Metric | BNTX | CNC |
|---|---|---|
| Revenue CAGR (5Y) | 2.16% | 11.48%● |
| EPS CAGR (5Y) | — | 14.68% |
| FCF CAGR (5Y) | — | 5.28% |
| Total return CAGR (5Y) | -15.29% | -3.98%● |
Frequently asked
- Which is better, BNTX or CNC?
- It depends on your goal. growth: CNC (faster 5Y revenue CAGR); quality: BNTX (higher ROIC). Across all compared metrics, CNC leads 6 to 4.
- Which has grown faster, BNTX or CNC?
- Over the past five years, CNC grew revenue faster — BNTX at a 2.16% CAGR versus CNC at 11.48%.
- Which has been the better investment, BNTX or CNC?
- Over the past 5-year, CNC delivered the higher annualized total return — BNTX at -15.29% versus CNC at 6.11%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioNTech SE P/E ratioCentene P/E ratioBioNTech SE dividend yieldCentene dividend yieldBioNTech SE ROECentene ROEBioNTech SE operating marginCentene operating marginBioNTech SE revenue growthCentene revenue growthBioNTech SE free cash flowCentene free cash flow
BioNTech SE & Centene appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 18, 2026.